Fundraising FoxIovance Biotherapeutics
Philadelphia, US · 2 known investors
Find your way into Iovance Biotherapeutics
Sign up to find every way you can get introduced to Iovance Biotherapeutics
- Your email: who you already know at Iovance Biotherapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Iovance Biotherapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Iovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.
Investors · 2
Founder mafia
3 people who came through Iovance Biotherapeutics went on to found or lead other companies.
Frequently asked questions
- What does Iovance Biotherapeutics do?
- Iovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.
- Who are Iovance Biotherapeutics's investors?
- Iovance Biotherapeutics's investors include Avoro Capital Advisors, Frazier Life Sciences.
- Where is Iovance Biotherapeutics headquartered?
- Iovance Biotherapeutics is headquartered in Philadelphia, US.